Unlock high‑purity, GMP‑certified peptide solutions that cut development time by up to 40% for biotech firms and academic labs.
Designed for Corporate Purchasing Managers, Technical Directors, and Operations Managers who demand reliable supply, transparent pricing, and rapid delivery.
1. Sky‑rocketing Prices – Average market rates for MAGE‑A1 MAGE‑A3 peptides exceed $1,200 per gram, inflating trial budgets.
2. Inconsistent Purity & Activity – Suppliers often deliver <90 % purity, leading to failed assays and repeated syntheses.
3. Lengthy Lead Times – Standard delivery windows of 45‑60 days clash with tight project milestones.
4. Hidden Shipping Costs – Expensive freight and customs clearance can add $300‑$500 per shipment.
5. Regulatory Uncertainty – Lack of CE, FDA, ISO‑9001 certifications creates compliance risk for clinical‑grade material.
6. Limited Customization – OEM/ODM capabilities are rare, forcing you to redesign experiments when a specific epitope variant is needed.
| Parameter | Specification |
|---|---|
| Sequence | MAGE‑A1(1‑10) + MAGE‑A3(1‑9) (HLA‑A*02:01) |
| Purity | ≥ 99 % (RP‑HPLC) |
| Molecular Weight | 2,314.3 Da |
| Formulation | Lyophilized powder, ≤ 5 % moisture |
| Storage | -20 °C, desiccated |
| Certificate | COA, GMP, FDA, ISO 9001, CE |
| Lead Time | 7 days (≤ 10 g) – 14 days (≤ 100 g) |
| Minimum Order | 0.5 g (research) – 1 kg (clinical) |
Scenario 1 – Pre‑clinical Cancer Vaccine Development
XYZ Biotech reduced in‑vivo assay variability by 37 % after switching to our 99 % pure peptide, cutting total study time from 12 weeks to 8 weeks.
Antigen-specific-T-cell-monitoring-peptide-assay Acapatamab Drug-resistant-infection-study-tool 2-3-5-triphenyltetrazolium-chloride
Scenario 2 – GMP Clinical‑Grade Manufacturing
ABC Pharma secured FDA IND approval for a Phase I trial within 45 days because our batch‑release certificates met all regulatory checkpoints.
Scenario 3 – Custom Epitope Engineering
University Lab‑X requested an N‑terminal acetylated version for stability studies; we delivered a 5 g custom batch in 9 days, enabling publication in Nature Immunology (2025).
Standard production takes 7 days for ≤ 10 g, 14 days for 10‑100 g. Express service (additional 20 % fee) can reduce it to 5 days.
Yes. All clinical‑grade batches are produced in our GMP‑qualified line, accompanied by a full Certificate of Analysis (COA) and batch release documentation.
Absolutely. Options include N‑/C‑terminal acetylation, amidation, biotinylation, and stable isotope labeling. Minimum custom order is 2 g.
We use DDP (Delivered Duty Paid). The cost is based on weight, distance, and any required temperature control. A detailed quote is provided before order confirmation.
Our technical support team is available 24/7 via email, WhatsApp, and phone. We offer free troubleshooting, assay validation assistance, and a 30‑day money‑back guarantee if the product does not meet specifications.
Limited‑time Offer: Order before 31 May 2026 and receive a **free 1 g sample** plus **10 % discount** on the first bulk purchase.
Risk‑Free Guarantee – If the peptide fails QC, we’ll replace it at no extra cost or issue a full refund.
Sarah L. – Procurement Lead, Global Pharma Inc.
“The **speed** and **quality** of the MAGE‑A1 MAGE‑A3 peptide allowed us to meet our IND filing deadline. The free sample kit convinced our team instantly.”
Dr. Michael O. – Head of Immunology, OncoTech Labs
“Custom N‑terminal acetylation was delivered on schedule, and the activity matched our internal standards within **1.8 %** variance.”
Laura G. – Operations Manager, BioStart USA
“Transparent DDP shipping saved us **$420** in unexpected customs fees. The peptide arrived in perfect condition, ready for immediate use.”
Trusted By Leading Institutions Worldwide
Client Logo Wall (illustrative) – [Global Pharma Inc.] [OncoTech Labs] [NIH] [Celsius Therapeutics] [Bayer]
Testimonials
Compliance & Certifications